Cerba HealthCare Changes Its Governance and Appoints Emmanuel Ligner Group Chief Executive Officer
Cerba HealthCare, a leading player in medical diagnostics, announces the appointment of Emmanuel Ligner as Chief Executive Officer of the Group. The Group has also strengthened its Supervisory Board with the appointment of Paul Navarre as Chairman and the appointments of Dr. Nuala Murphy and Benoît Ribadeau-Dumas. Their international track records and deep healthcare expertise will support the Group’s expansion in Europe, Africa and North America in clinical pathology for clinical trials, routine and specialty clinical pathology. Cerba HealthCare aims to remain at the forefront of medical innovation to help develop new treatments and improve patient health.
Emmanuel Ligner, Group Chief Executive Officer, said: « Cerba HealthCare is a leading company in the field of medical diagnostics as evidenced by the Group’s growth and the importance it has placed on innovation since its very inception. I am honored to join Cerba HealthCare at this key moment in its history where the expertise of the Group -ranging from routine clinical pathology to clinical pathology for assays- makes it possible to meet the challenges of the personalized medicine of tomorrow. I look forward to joining the management team and meeting with the employees. Together, we will build the next chapter of Cerba HealthCare. »
Paul Navarre, Chairman of the Supervisory Board, adds: « I am very pleased to join the Supervisory Board of Cerba HealthCare, which will invest all its energy and skills into the implementation of our international deployment strategy and the completion of the transformation plan already underway. With Emmanuel’s appointment, the Group is in an excellent position to carry out its growth strategy, powered by its ability to innovate and consolidate its positions across businesses and geographic markets. »
Jérôme Thill, Senior Advisor and former Chief Executive Officer of the Group, adds: « As I step down as Chief Executive Officer, I would like to thank all of Cerba HealthCare’s teams and partners. I wish Emmanuel Ligner and the whole team every success in their new roles.»
Emmanuel Ligner will join Cerba HealthCare on March 1st, 2024. Until then, Paul Navarre will act as the Group’s CEO, with the support of Jérôme Thill, as Senior Advisor, and of Philippe Buhl, as Managing Director.
####
Emmanuel Ligner has had a distinguished career in the healthcare sector. As Chairman and CEO of Cytiva (formerly GE HealthCare Life Sciences) since 2017, he has accelerated the growth trajectory of the group, which doubled sales in recent years. Before taking the helm at Cytiva, Emmanuel held a number of key positions in North America, Europe, the Middle East and Africa. Emmanuel began his career in the late 90s in Japan with Otsuka Pharmaceutical before joining Abbott.
Paul Navarre spent 30 years in management positions at Procter & Gamble, Allergan (President) and Ferring Inc (CEO). He is currently a member of the board of directors of several companies around the world (LEO Pharma, HTL, Hallura) and advises private equity funds.
Dr. Nuala Murphy, a neuroscientist by training, has held senior international positions in the pharmaceutical industry, most recently as President of Development and Commercialization at ICON Plc. In addition to joining the Supervisory Board of Cerba HealthCare, Nuala will take on the role of Executive Chair of Cerba Research.
Benoît Ribadeau-Dumas spent 15 years in senior management positions in the industry sector (Thales, CGG, Zodiac Aerospace), before becoming Chief of Staff to French Prime Minister Edouard Philippe from 2017 to 2020. Benoît is now Managing Director at Exor and a member of various boards, including Stellantis, Iveco, Institut Mérieux and Galileo Global Education.
####
About Cerba HealthCare
Cerba HealthCare, a leading global player in medical diagnostics, aims to support the evolution of health systems towards more prevention. It draws on more than 50 years of expertise in clinical pathology to better assess the risk of diseases development, detect and diagnose diseases earlier, and optimize the effectiveness of personalized medicine.
Every day, on five continents, the Group's 15,000 employees sustain the transformation of medicine, driven by one deep conviction: to advance diagnosis is to advance health.
Cerba HealthCare, enlightening health.
Additional information is available at www.cerbahealthcare.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231109943506/en/
Contact information
Press contact:
Cerba HealthCare
Emmanuelle Saby
+33 6 09 10 76 10
emmanuelle.saby@cerbahealthcare.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AudioCure Pharma Receives Hearing Technology Innovator Award for its Innovative Compound AC102 for the Treatment of Sudden Hearing Loss7.12.2023 10:05:00 CET | Press release
AudioCure Pharma GmbH announced today that it has been awarded for its innovative compound AC102 by the Hearing Technology Innovator Awards™, honoring technological innovation and breakthroughs in the hearing industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231205308215/en/ Dr. Reimar Schlingensiepen (left, CEO of AudioCure Pharma GmbH) and Prof. Hans Rommelspacher (founder and CSO) receive the award in the therapeutics category. (Photo: AudioCure Pharma) AudioCure is developing the therapeutic small molecule AC102 to treat hearing impairments including Sudden Sensorineural Hearing Loss (SSNHL). While corticosteroids are the standard treatment, health authorities have never approved them as there is no clear evidence of a clinically relevant benefit to the patient. AudioCure is conducting extensive research to develop targeted and effective therapies to address this high unmet medical need. In preclinical hearing los
FourKites Unveils Supply Chain Training Platform to Help Customers Maximise Value and Increase ROI7.12.2023 10:03:00 CET | Press release
Leading supply chain visibility provider FourKites today announces the availability of FourKites Academy, a comprehensive training platform designed to help supply chain professionals advance in their careers and business goals with high-quality, industry-recognised training resources. In addition to offering a Council of Supply Chain Management Professionals (CSCMP)-accredited course, the Academy helps FourKites customers and their extended ecosystem — including third-party logistics providers (3PLs), carriers, brokers and transportation management partners — keep pace with FourKites’ latest innovations and derive maximum value from the platform. According to research from the 2023 MHI Annual Industry Report, hiring and retaining qualified workers is the top challenge for supply chain leaders, with 41% indicating that reskilling and training their workforce is key to preparing for future disruptions. “Through FourKites Academy, we are empowering supply chain professionals with new ski
The 5th World Media Summit (Yunnan Branch) and the 2nd Yunnan International Communication Forum Kicks off in Kunming, China7.12.2023 09:43:00 CET | Press release
The 5th World Media Summit (Yunnan Branch) and the 2nd Yunnan International Communication Forum kicked off on December 6, 2023, in Kunming, the capital city of Yunnan Province in Southwestern China, gathering more than 300 representatives of around 80 institutions, including media outlets, international organizations and think tanks, from nearly 30 countries and regions . This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231206795498/en/ The 5th World Media Summit (Yunnan Branch) and the 2nd Yunnan International Communication Forum kicks off in Kunming on Dec. 5 (Photo: Business Wire) The opening of the summit on December 5 witnessed the adoption of the Kunming Initiative, the launch of a theme activity named "A Lifestyle Called Yunnan", as well as the release of the list of trending words for international communication generated by Xinhuanet. According to the agenda of the summit, the attendees will discuss a variety of topic
euNetworks’ CEO delivers insight at COP28 on the company’s sustainability focus7.12.2023 09:00:00 CET | Press release
euNetworks Group Limited (“euNetworks”), a Western European bandwidth infrastructure company, was recently featured in an interview series with leaders from across industries undertaken during the United Nations Climate Conference (COP28) in Dubai. The series of interviews captures lessons learned, sustainability success stories and key messages for the future from leaders across the energy, technology and telecom, manufacturing and finance industries. euNetworks has also released its latest Sustainability Report, detailing the company’s commitment to sustainability and substantial progress over the last year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231207410743/en/ Paula Cogan, CEO of euNetworks (Photo: Business Wire) euNetworks builds and invests in city and long haul fibre networks to connect key European data centres and data hubs. The company owns and operates deep fibre networks in 17 cities and also operates a
Ecopol Announces Strategic Investment in JRF Technology7.12.2023 09:00:00 CET | Press release
Ecopol S.p.A. (“Ecopol”), a leading developer and producer of innovative biodegradable films and delivery systems, announced today it has completed a strategic investment in JRF Technology LLC (“JRF” or the “Company”), a leading developer of water-soluble polymer and edible film technology. Founded in 2007 and based in Tampa, Florida, JRF is an innovation and R&D organization focused exclusively on water-soluble polymer and edible film technology. From its state-of-the-art GMP laboratory, JRF provides innovation services to clients ranging from leading multinational consumer goods companies to innovative start-ups. The Company has unique expertise in product development and process technology to convert water-soluble polymers into value-added commercial products. JRF will continue to be led by President James Rossman and Managing Director Richard Fielder and will serve as Ecopol’s U.S. R&D Center of Excellence, complementing its R&D capabilities in Italy. “Our strategic investment in J